Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit Accumulated [Member]
Total
Beginning balance, shares at Dec. 31, 2016 199,045,026      
Beginning balance, value at Dec. 31, 2016 $ 199,045 $ 103,716,955 $ (105,274,000) $ (1,358,000)
Common stock issued for cash, shares 181,355      
Common stock issued for cash, value $ 181 37,819   38,000
Common stock issued on exercise of options and warrants, shares 4,245,752      
Common stock issued on exercise of options and warrants, value $ 4,246 357,754   362,000
Common stock issued on conversion of notes payable, shares issued 29,876,772      
Common stock issued on conversion of notes payable, value $ 29,877 1,492,123   1,522,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   1,469,000   1,469,000
Fair value of options and warrants issued as compensation   653,000   653,000
Net loss     (4,145,000) (4,145,000)
Ending balance, shares at Sep. 30, 2017 233,348,905      
Ending balance, value at Sep. 30, 2017 $ 233,349 $ 107,726,651 $ (109,419,000) $ (1,459,000)